Updated Jul 16, 2026
Feinberg Peter has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $226K. Historical track record: 2/5 stars across 4 tracked purchases.

| Role | Director |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★☆☆☆ (2/5) |
|---|---|
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 5000% |
| 90-day win rate | 5000% |
| Avg 5-day return | +86.49% |
| Avg 30-day return | +306.55% |
| Avg 90-day return | +957.55% |
| Best 30-day return | +1966.82% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-15 | IMRX | Immuneering Corp | P — Open-market purchase | 20.0K | $4.35 | $87K |
| 2025-10-03 | IMRX | Immuneering Corp | P — Open-market purchase | 7.5K | $6.67 | $50K |
| 2025-09-30 | IMRX | Immuneering Corp | P — Open-market purchase | 7.5K | $7.03 | $53K |
| 2025-09-29 | IMRX | Immuneering Corp | P — Open-market purchase | 5.0K | $7.18 | $36K |
Feinberg Peter is a corporate insider — currently tracked as Director of Immuneering Corp (IMRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 4 open-market purchases ($226K) and 0 open-market sales () across all tracked filings.
Across 4 tracked purchases, Feinberg Peter averaged +306.6% avg 30-day return with a 5000% 30-day win rate. InsiderAlpha rates the track record at 2/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Feinberg Peter profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.